10:35:31 EDT Sun 19 May 2024
Enter Symbol
or Name
USA
CA



T:MSCL - SATELLOS BIOSCIENCE INC. - https://satellos.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MSCL - T  3.00.45·0.495.00.47-0.01-2.113.06110.485  0.485  0.470.80  0.2915:55:52May 1515 min RT 2¢
TSX - T3.00.45·0.495.00.47-0.01-2.13.5140.47  0.47  0.470.80  0.2915:55:5215 min
NEO ATS - U 0.47-0.01-2.12.5110.47  0.47  0.4715:55:5015 min
Omega - O 0.47-0.01-2.13.5220.485  0.485  0.4715:55:5015 min
Pure - P 0.47-0.01-2.10.5010.47  0.47  0.4715:55:5015 min
CX2 - H 0.47-0.01-2.13.0130.47  0.47  0.4715:55:5015 min

Recent Trades - Last 10 of 11
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:55:52T0.47-0.011,00079 CIBC7 TD SecK
15:55:50O0.47-0.015001 Anonymous7 TD SecK
15:55:50P0.47-0.015001 Anonymous7 TD SecK
15:55:50H0.47-0.011,0002 RBC7 TD SecK
15:55:50H0.47-0.011,0001 Anonymous7 TD SecK
15:55:50H0.47-0.011,0001 Anonymous7 TD SecK
15:55:50U0.47-0.012,5001 Anonymous7 TD SecK
15:55:50T0.47-0.011,0007 TD Sec7 TD SecK
15:55:50T0.47-0.015007 TD Sec7 TD SecK
15:55:50T0.47-0.011,0007 TD Sec7 TD SecKL

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-05-14 17:43C:MSCL0.47News ReleaseSatellos Bioscience holders approve all matters at AGSM
2024-05-14 14:08C:MSCL0.48SEDAR Interim MD & ASEDAR Interim MD & A
2024-05-14 14:02C:MSCL0.48SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-05-14 11:59C:MSCL0.48News ReleaseSatellos Bioscience's March 31 cash at $33.2-million
2024-03-27 16:42C:MSCL0.48SEDAR MD & ASEDAR MD & A
2024-03-27 15:50C:MSCL0.46SEDAR MD & ASEDAR MD & A
2024-03-27 15:44C:MSCL0.46SEDAR Annual Information FormSEDAR Annual Information Form
2024-03-27 15:44C:MSCL0.46SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-03-27 11:14C:MSCL0.48News ReleaseSatellos Bioscience's Dec. 31 cash at $39.6-million
2024-02-14 11:10C:MSCL0.55News ReleaseSatellos Bioscience to begin trading on TSX Feb. 15
2024-02-13 19:56C:MSCL0.55Shares Delisted from TSX-VSatellos Bioscience to be delisted from TSX-V
2024-02-13 15:01C:MSCL0.55New ListingSatellos Bioscience to trade on TSX Feb. 15
2024-02-13 11:19C:MSCL0.53News ReleaseSatellos Bioscience releases SAT-3247 preliminary data
2024-01-26 11:38C:MSCLSEDAR Final Short Form ProspectusSEDAR Final Short Form Prospectus
2024-01-23 10:08C:MSCL0.55News ReleaseSatellos names Dubow chief medical adviser
2024-01-16 11:45C:MSCL0.45News ReleaseSatellos Bioscience receives cond. OK for TSX listing
2023-11-22 14:30C:MSCL0.50SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-22 14:28C:MSCL0.50SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-22 10:41C:MSCL0.475News ReleaseSatellos Bioscience's Sept. 30 cash at $44.3-million
2023-11-14 13:38C:MSCL0.35News ReleaseSatellos sets AAK1 as drug target to treat Duchenne